Homecare Delivery Service for Clotting Factors
A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- 2 year (est.)
- Value
- £2M
- Sector
- HEALTH
- Published
- 21 Dec 2023
- Delivery
- To 08 Feb 2026 (est.)
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
2 buyers
- NHS National Services Scotland NSS Edinburgh
2 suppliers
- Healthcare At Home Burton upon Trent
- Lloydspharmacy Clinical Homecare Harlow
Description
The provision of a Homecare Delivery Service within NHS Scotland to hospitals and patients' homes or other designated address.
Total Quantity or Scope
Provision of a Homecare Delivery Service to deliver Clotting Factors to patients in NHS Scotland. This includes the dispensing and delivery of the prescribed medicines along with ancillary products, as required, to patients in their homes or other agreed designated delivery points, and to provide removal of sharps containers as detailed within the specification contained within the tender documentation. The framework agreement was awarded as a unranked multi-supplier framework two (2) suppliers.
Award Detail
1 | Healthcare At Home (Burton upon Trent)
|
2 | Lloydspharmacy Clinical Homecare (Harlow)
|
CPV Codes
- 33600000 - Pharmaceutical products
- 33141510 - Blood products
Indicators
Legal Justification
This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.
Other Information
The estimated value(s) of the Framework Agreement referred to in Section V.2.4 cover(s) the twelve (12) month duration of the proposed modification period of the Framework Agreement. (SC Ref:753853)
Reference
- FTS 037711-2023